Neural circuit optimization occurs through sensory activity-dependent mechanisms that refine synaptic connectivity and information processing during early-use developmental critical periods. Fragile X Mental Retardation Protein (FMRP), the gene product lost in Fragile X syndrome (FXS), acts as an activity sensor during critical period development, both as an RNA-binding translation regulator and channel-binding excitability regulator. Here, we employ a Drosophila FXS disease model to assay calcium signaling dynamics with a targeted transgenic GCaMP reporter during critical period development of the mushroom body (MB) learning/memory circuit. We find FMRP regulates depolarization-induced calcium signaling in a neuron-specific manner within this circuit, suppressing activity-dependent calcium transients in excitatory cholinergic MB input projection neurons and enhancing calcium signals in inhibitory GABAergic MB output neurons. Both changes are restricted to the developmental critical period and rectified at maturity. Importantly, conditional genetic (dfmr1) rescue of null mutants during the critical period corrects calcium signaling defects in both neuron classes, indicating a temporally restricted FMRP requirement. Likewise, conditional dfmr1 knockdown (RNAi) during the critical period replicates constitutive null mutant defects in both neuron classes, confirming cell-autonomous requirements for FMRP in developmental regulation of calcium signaling dynamics. Optogenetic stimulation during the critical period enhances depolarization-induced calcium signaling in both neuron classes, but this developmental change is eliminated in dfmr1 null mutants, indicating the activity-dependent regulation requires FMRP. These results show FMRP shapes neuron class-specific calcium signaling in excitatory vs. inhibitory neurons in developing learning/memory circuitry, and that FMRP mediates activity-dependent regulation of calcium signaling specifically during the early-use critical period.
Introduction
Fragile X syndrome (FXS) is the leading heritable cause of intellectual disability (Boyle and Kaufmann, 2010) and most prevalent single-gene autism spectrum disorder (Wang et al., 2012) . The disease state is caused by lack of Fragile X Mental Retardation Protein (FMRP), a key regulator of activity-dependent neural circuit modulation during critical period development (Doll and Broadie, 2014) . The full range of FMRP function is broad and inconclusive, but includes regulation of multiple classes of voltagegated ion channels, via both RNA-binding translational control (Gross et al., 2011; Lee et al., 2011; Strumbos et al., 2010) and direct channelbinding interactions (Brown et al., 2010; Deng et al., 2013; Ferron et al., 2014; Zhang et al., 2014) . Downstream, FMRP also regulates numerous calcium-binding proteins (CaBPs) involved in activity-dependent calcium signaling (Chen et al., 2003; Tessier and Broadie, 2011; Wang et al., 2009 ). Consistently, FXS disease models exhibit increased excitatory neurotransmission (Deng et al., 2013; Deng et al., 2011; Gibson et al., 2008) , defects in action potential termination (Brown et al., 2010; Deng et al., 2013; Zhang et al., 2012) and altered depolarization-triggered calcium influx (Deng et al., 2013; Deng et al., 2011; Ferron et al., 2014; Patel et al., 2013; Tessier and Broadie, 2011) . Earlier work has elegantly mapped critical period functional refinement (Meredith, 2015) , and defining FMRP roles in these activity-dependent mechanisms at single cell resolution during critical periods is now possible through the application of incisive Drosophila genetics.
The Drosophila FXS disease model has long been instrumental in dissecting developmental and activity-dependent FMRP roles (Doll and Broadie, 2015; Gatto and Broadie, 2008; Pan et al., 2004; Tessier and Broadie, 2008; Weisz et al., 2015; Zhang et al., 2001) . Our past studies have identified hyper-excitability, calcium influx and store release defects, and changes in CaBP expression in the absence of FMRP function (Gatto and Broadie, 2008; Repicky and Broadie, 2009; Tessier and Neurobiology of Disease 89 (2016) 76-87 
